Restricted Content: Healthcare and Medicines

What it is

The policy requires prior Google authorization for ads promoting prescription drugs, unapproved pharmaceuticals and supplements, and health claims that may be misleading. Advertisers in these categories must obtain Google certification before ads can serve.

Why it matters (compliance & governance perspective)

This provision creates a pre-authorization requirement for pharmaceutical and healthcare advertisers that operates independently of and in addition to regulatory approvals from the FDA or equivalent national authorities, meaning regulatory compliance alone does not establish Google Ads eligibility.

Consumer impact (what this means for users)

The agreement requires advertisers in healthcare and pharmaceutical categories to obtain prior Google authorization, which means compliant pharmaceutical advertisers who have not completed Google's certification process cannot serve ads through the platform. Advertisers must apply for and receive category-specific certification through the Google Ads certification program.

What you can do

Institutional analysis (Compliance & governance intelligence)

1) REGULATORY LANDSCAPE: Healthcare and pharmaceutical advertising in the US is subject to FDA regulations governing prescription drug advertising, including requirements for fair balance and disclosure of risks. The FTC has authority over health claims in advertising under section 5 of the FTC Act and the FTC Act's prohibitions on unsubstantiated health claims. In the EU, Directive 2001/83/EC governs medicinal product advertising. The policy's reference to unapproved pharmaceuticals and supplements also engages FTC and FDA enforcement postures on dietary supplement health claims. 2) GOVERNANCE EXPOSURE: High for healthcare and pharmaceutical advertisers. The certification requirement is an operational prerequisite for platform access, and advertisers who run campaigns without completing certification face ad disapproval and account action. Advertisers promoting supplements with health claims face a dual compliance obligation: satisfying FTC substantiation requirements and satisfying Google's authorization process. 3) JURISDICTION FLAGS: Prescription drug advertising directly to consumers is prohibited in most jurisdictions outside the US and New Zealand. Advertisers targeting EU users must assess whether their campaigns comply with Directive 2001/83/EC restrictions on direct-to-consumer prescription drug advertising. Country-specific restrictions within the Google Ads policy may impose additional limitations beyond what the base policy states. 4) CONTRACT AND VENDOR IMPLICATIONS: Healthcare advertisers using agencies to manage Google Ads campaigns should confirm that agencies have completed required certifications and that account structures maintain certification status. Changes in product formulation, claims, or regulatory status should trigger re-review of certification eligibility. 5) COMPLIANCE CONSIDERATIONS: Legal teams should confirm current Google Healthcare certification status for all product categories advertised and maintain documentation of FDA or equivalent regulatory approval for all promoted products. Health claims used in ad copy should be reviewed against both FTC substantiation standards and Google's editorial requirements for misleading health claims.

Applicable agencies

Provision details

Other risks in this policy

• Prohibited Content: Counterfeit Goods high
• Prohibited Content: Dangerous Products and Services high
• Prohibited Practices: Data Collection and Use Violations high
• Prohibited Practices: Circumventing Systems high
• Restricted Content: Financial Products and Services high
• Restricted Content: Political Advertising medium